Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | GRM8 | O00222 | 1/20 | 0.62 |
| ▸ | GRM6 | O15303 | 1/20 | 0.62 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.62 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.62 |
| ▸ | GSR | P00390 | 1/20 | 0.62 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.62 |
| ▸ | GRM5 | P41594 | 1/20 | 0.62 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.62 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.62 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.62 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.62 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.62 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.62 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.62 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.62 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.62 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Glutamate SCHEMBL6738798 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL16336 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL218574 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL11884703 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL1782280 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL8746869 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL1899059 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL1532402 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL5184074 | 0.95 | GRM8 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B | |
| D-Glutamate SCHEMBL5207959 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024253189-A1 | PROPHYLACTIC AND/OR AMELIORATING AGENT FOR PERIPHERAL NEUROPATHY CAUSED BY CANCER CHEMOTHERAPEUTIC AGENT | 国立大学法人 富山大学 | 2024-12-12 | — | — | WO | claimed |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ISP INVESTMENTS LLC (US) | 2022-01-18 | — | — | US | claimed |
| CN-113735729-A | Production process of feed-grade ferrous glutamate | 四川吉隆达生物科技集团有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-107613954-B | Synergistic compositions of dehydroacetic acid and methods of reducing yellowing in various end-use compositions | ISP投资有限公司 | 2021-10-19 | — | — | CN | claimed |
| CN-109180510-B | Preparation method of high-purity ferrous glutamate | 长沙兴嘉生物工程股份有限公司 | 2021-08-24 | — | — | CN | claimed |
| WO-2021137780-A1 | PREPARATION OF FILM TABLET COMPOSITION COMPRISING HEME IRON FOR IRON DEFICIENCY | İLKO İLAÇ SANAYİ VE TİCARET A.Ş. (TR) | 2021-07-08 | — | — | WO | claimed |
| EP-3216782-B1 | IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF | NPA NUCLEO DE PESQUISAS APLICADAS LTDA (BR) | 2021-06-02 | — | — | EP | claimed |
| US-20210122705-A1 | IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF | NPA NUCLEO DE PESQUISAS APLICADAS LTDA (BR) | 2021-04-29 | — | — | US | claimed |
| CN-112675160-A | Amino acid mineral salt trace element composition and preparation method thereof | 河北力维素科技有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-110791277-A | Fracturing fluid capable of being converted into oil displacement agent without flowback for oil field and preparation method thereof | 西安石油大学 | 2020-02-14 | — | — | CN | claimed |
| EP-0966209-A1 | COOKED CEREAL INGREDIENT-CONTAINING PRODUCTS FORTIFIED WITH EDTA/IRON COMPOSITIONS AND METHODS FOR USE | KELLOGG COMPANY (US) | 1999-12-29 | — | — | EP | claimed |
| WO-1999005920-A1 | COOKED CEREAL INGREDIENT-CONTAINING PRODUCTS FORTIFIED WITH EDTA/IRON COMPOSITIONS AND METHODS FOR USE | KELLOGG COMPANY (US) | 1999-02-11 | — | — | WO | claimed |
| US-5869084-A | SPECIFIC REGIMENS FOR LACTATING, NON-LACTATING AND MENOPAUSAL WOMEN | K-V PHARMACEUTICALS CO. (US) | 1999-02-09 | — | — | US | claimed |
| EP-0748166-A4 | READY-TO-EAT CEREAL PRODUCT FORTIFIED WITH FERRIC EDTA | KELLOG CO (US) | 1997-07-16 | — | — | EP | claimed |
| EP-0748166-A1 | READY-TO-EAT CEREAL PRODUCT FORTIFIED WITH FERRIC EDTA | KELLOGG COMPANY (US) | 1996-12-18 | — | — | EP | claimed |
| US-5534275-A | Foodstuffs containing a cereal ingredient and ferric EDTA | KELLOGG COMPANY (US) | 1996-07-09 | — | — | US | claimed |
| WO-1995035098-A1 | MULTI-VITAMIN AND MINERAL SUPPLEMENTS FOR WOMEN | KV PHARMACEUTICAL COMPANY (US) | 1995-12-28 | — | — | WO | claimed |
| WO-1995022908-A1 | READY-TO-EAT CEREAL PRODUCT FORTIFIED WITH FERRIC EDTA | KELLOGG COMPANY (US) | 1995-08-31 | — | — | WO | claimed |
| US-5045337-A | Mixture of lipid, polar solvent, and polyglycerol | THE PROCTER & GAMBLE COMPANY (US) | 1991-09-03 | — | — | US | claimed |
| EP-0366058-A2 | Controlled-release delivery device, method for producing device, and method of using device | ABBOTT LABORATORIES (US) | 1990-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210122705-A1 | IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF | HAMP, FECH, TFRC | CYP1A2 2124/4885GRM8 1646/4885GRM6 712/4885 |
| US-11224222-B2 | Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions | ALAD, SCD, DHCR7 | CYP1A2 264/4885GRM8 3496/4885GRM6 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.